Novartis Aktie
103,50
EUR
-0,70
EUR
-0,67
%
97,78
CHF
+0,26
CHF
+0,27
%
Werbung
Novartis Aktie Analyse
19.05.21 | Novartis Underweight | JP Morgan Chase & Co. | |
19.05.21 | Novartis buy | Deutsche Bank AG | |
14.05.21 | Novartis buy | UBS AG | |
11.05.21 | Novartis buy | Deutsche Bank AG | |
10.05.21 | Novartis buy | UBS AG | |
30.04.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
30.04.21 | Novartis buy | Deutsche Bank AG | |
28.04.21 | Novartis Underweight | Barclays Capital | |
Werbung
|
|||
28.04.21 | Novartis Neutral | Credit Suisse Group | |
28.04.21 | Novartis buy | Deutsche Bank AG | |
28.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
27.04.21 | Novartis buy | Jefferies & Company Inc. | |
27.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
27.04.21 | Novartis Underweight | Barclays Capital | |
27.04.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
27.04.21 | Novartis buy | UBS AG | |
27.04.21 | Novartis market-perform | Bernstein Research | |
22.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
09.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
07.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
23.03.21 | Novartis Underweight | JP Morgan Chase & Co. | |
23.03.21 | Novartis buy | Jefferies & Company Inc. | |
23.03.21 | Novartis market-perform | Bernstein Research | |
23.03.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
22.03.21 | Novartis market-perform | Bernstein Research | |
10.03.21 | Novartis buy | Deutsche Bank AG | |
09.03.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
09.03.21 | Novartis buy | Jefferies & Company Inc. | |
18.02.21 | Novartis buy | UBS AG | |
18.02.21 | Novartis buy | Deutsche Bank AG | |
16.02.21 | Novartis buy | Deutsche Bank AG | |
10.02.21 | Novartis buy | Deutsche Bank AG | |
09.02.21 | Novartis buy | Deutsche Bank AG | |
03.02.21 | Novartis buy | UBS AG | |
03.02.21 | Novartis Underweight | JP Morgan Chase & Co. | |
27.01.21 | Novartis Neutral | Credit Suisse Group | |
26.01.21 | Novartis buy | UBS AG | |
26.01.21 | Novartis overweight | Morgan Stanley | |
26.01.21 | Novartis Hold | Kepler Cheuvreux | |
26.01.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
26.01.21 | Novartis buy | Jefferies & Company Inc. | |
25.01.21 | Novartis Neutral | Oddo BHF | |
22.01.21 | Novartis Underweight | Barclays Capital | |
21.01.21 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
20.01.21 | Novartis Neutral | Credit Suisse Group | |
20.01.21 | Novartis buy | Jefferies & Company Inc. | |
19.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
15.01.21 | Novartis buy | Deutsche Bank AG | |
14.01.21 | Novartis buy | UBS AG | |
13.01.21 | Novartis Underweight | JP Morgan Chase & Co. |
Werbung
Werbung